We are live on ! Find out more
MG

Marex Group Portfolio holdings

AUM $15.8B
1-Year Est. Return 31.44%
This Fund
S&P 500
This Quarter Est. Return
+14.33%
1 Year Est. Return
+31.44%
3 Year Est. Return
+143.62%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.87B
AUM Growth
+$1.49B
Cap. Flow
+$1.04B
Cap. Flow %
17.74%
Top 10 Hldgs %
45.81%
Holding
854
New
240
Increased
190
Reduced
182
Closed
177

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$272M
2
SMCI icon
Super Micro Computer
SMCI
+$243M
3
NVDA icon
NVIDIA
NVDA
+$159M
4
SYK icon
Stryker
SYK
+$157M
5
AMD icon
Advanced Micro Devices
AMD
+$110M

Top Sells

Rank Stock Value
1
MSTR icon
Strategy Inc
MSTR
+$176M
2
COST icon
Costco
COST
+$104M
3
LIN icon
Linde
LIN
+$90.8M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$72.6M
5
BLK icon
Blackrock
BLK
+$69.6M

Sector Composition

Rank Sector Weight
1 Technology 36.26%
2 Consumer Discretionary 17.72%
3 Healthcare 12.15%
4 Financials 6.53%
5 Industrials 4.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NKLA
651
DELISTED
Nikola Corporation Common Stock
NKLA
$27.3K ﹤0.01%
22,922
+3,478
+18% +$9.93K
RAY
652
Raytech Holding Ltd
RAY
$14.3M
$26.9K ﹤0.01%
1,295
-1,302
-50% -$31.8K
ORGN
653
DELISTED
Origin Materials
ORGN
$25.6K ﹤0.01%
667
– –
PDSB icon
654
PDS Biotechnology
PDSB
$39.2M
$22.8K ﹤0.01%
14,000
– –
IMUX icon
655
Immunic
IMUX
$195M
$22.5K ﹤0.01%
+2,250
New +$28.4K
TSHA icon
656
Taysha Gene Therapies
TSHA
$1.68B
$21.6K ﹤0.01%
12,500
– –
ASNS
657
DELISTED
ACTELIS NETWORKS INC
ASNS
$19.3K ﹤0.01%
+1,441
New +$18.4K
WKHS icon
658
Workhorse Group
WKHS
$30.1M
$13.1K ﹤0.01%
125
+29
+30% +$3.96K
CLRCR
659
DELISTED
ClimateRock Right
CLRCR
$10.5K ﹤0.01%
151,384
+842
+0.6% +$56
MNDR
660
Mobile-health Network Solutions
MNDR
$3.14M
$10.2K ﹤0.01%
+133
New +$12.4K
TANH icon
661
Tantech Holdings
TANH
$6.23M
$8.44K ﹤0.01%
1,000
+452
+82% +$3.01K
NIVF
662
NewGenIvf
NIVF
$4.17M
– –
0
– –
SPRB
663
Spruce Biosciences
SPRB
$124M
$6.22K ﹤0.01%
197
– –
CAPTW
664
DELISTED
Captivision Inc Warrant
CAPTW
$5.27K ﹤0.01%
527,155
– –
TNXP icon
665
Tonix Pharmaceuticals
TNXP
$169M
$4.72K ﹤0.01%
143
-235
-62% -$4.88K
BNBX
666
DELISTED
BNB PLUS CORP
BNBX
$4.24K ﹤0.01%
+28
New +$4.86K
SYRS
667
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$3.84K ﹤0.01%
16,700
+4,000
+31% +$4.8K
ORGNW
668
DELISTED
Origin Materials Inc Warrants
ORGNW
$3.75K ﹤0.01%
30,000
– –
BNIXR
669
DELISTED
Bannix Acquisition Corp. Right
BNIXR
$3.5K ﹤0.01%
36,396
+1,272
+4% +$117
CRKN
670
DELISTED
Crown Electrokinetics Corp. Common Stock
CRKN
$2.21K ﹤0.01%
+104
New +$11.5K
GOVXW
671
DELISTED
GeoVax Labs Warrants
GOVXW
$1K ﹤0.01%
10,000
– –
BNIXW
672
DELISTED
Bannix Acquisition Corp. Warrant
BNIXW
$937 ﹤0.01%
33,951
-850
-2% -$18
KTTAW icon
673
Pasithea Therapeutics Warrants
KTTAW
$26K
$925 ﹤0.01%
25,000
– –
CERO
674
DELISTED
CERo Therapeutics
CERO
$900 ﹤0.01%
+8
New +$1.86K
MNYWW
675
MoneyHero Ltd Warrants
MNYWW
$625 ﹤0.01%
11,320
– –
25 26
27
28 29

Similar funds

CLGM
Capitolis Liquid Global Markets New York $15.7B AUM 30.78% 1-Year Est. Return
LCIP
Life Cycle Investment Partners London $15.7B AUM
EF
Empowered Funds Havertown, Pennsylvania $15.7B AUM 34.02% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return
OAC
OMERS Administration Corp Toronto, Ontario, Canada $15.6B AUM 24.73% 1-Year Est. Return
EH
Equitable Holdings New York $15.5B AUM 19.09% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
NMO
Newlands Management Operations Dallas, Texas $15.5B AUM 25.52% 1-Year Est. Return

Marex Group's Q4 2024 Portfolio in Review

As of Q4 2024, Marex Group held 854 positions worth $5.87B, up 34% from $4.38B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Marex Group deployed $1.04B of net new capital in Q4 2024, opening 240 new positions and adding to 190 existing holdings. Its largest new stake was Hilton Worldwide: 225,008 shares worth $55.6M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 32% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Strategy Inc, an estimated $176M trimmed.

  • Marex Group's largest Q4 2024 buy was Hilton Worldwide: 225,008 shares worth $55.6M.
  • Marex Group added most to Tesla in Q4 2024, an estimated $272M increase.
  • Marex Group's biggest Q4 2024 reduction was Strategy Inc, cutting an estimated $176M.
  • Marex Group fully exited Cigna in Q4 2024, selling an estimated $34.7M.
  • Marex Group's ten largest holdings make up 46% of its $5.87B portfolio in Q4 2024.
  • Marex Group opened 240 new positions and closed 177 in Q4 2024.
  • Marex Group's portfolio value rose 34% quarter-over-quarter to $5.87B.

Based on Marex Group's 13F filing for Q4 2024, filed 2 Apr 2026.